BGI
ADMA icon

B Group Inc’s ADMA Biologics ADMA Stock Holding History

B Group Inc’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
3,262,542
+55,000
+2% +$501K 12.82% 2
2026
Q1 		$28.9M Buy
3,207,542
+750,000
+31% +$11.8M 21.43% 1
2025
Q4 		$44.8M Buy
2,457,542
+45,000
+2% +$758K 33.1% 1
2025
Q3 		$35.4M Buy
2,412,542
+95,000
+4% +$1.63M 26.02% 1
2025
Q2 		$42.2M Hold
2,317,542
– – 32.48% 1
2025
Q1 		$46M Buy
2,317,542
+30,000
+1% +$519K 39.39% 1
2024
Q4 		$39.2M Buy
+2,287,542
New +$43M 23.98% 2

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

B Group Inc's ADMA Position: Q2 2026 in Review

B Group Inc increased its ADMA Biologics (ADMA) stake by 1.7% in Q2 2026, buying an estimated $501K and bringing the position to 3,262,542 shares worth $27.3M. The position accounts for 12.82% of the portfolio, ranked #2.

B Group Inc first reported a position in ADMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $46M in Q1 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • B Group Inc held 3,262,542 shares of ADMA Biologics worth $27.3M as of Q2 2026.
  • B Group Inc bought 55,000 ADMA Biologics shares in Q2 2026, an estimated $501K.
  • ADMA Biologics made up 12.82% of B Group Inc's portfolio in Q2 2026, its #2 holding.
  • B Group Inc first reported a position in ADMA Biologics in Q4 2024 and has held it in 7 quarters since.
  • B Group Inc's ADMA Biologics position peaked at $46M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.